JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand flag Thailand · Delayed Price · Currency is THB
1.940
0.00 (0.00%)
Feb 5, 2026, 3:48 PM ICT

BKK:JSP Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
993.15824.49575.58458.07422.34455.64
Other Revenue
13.8821.4518.788.736.787.1
1,007845.93594.36466.8429.13462.74
Revenue Growth (YoY)
30.95%42.33%27.32%8.78%-7.27%25.29%
Cost of Revenue
589.17519.49432.06313.11277.97310.02
Gross Profit
417.86326.44162.3153.69151.15152.73
Selling, General & Admin
306.55221.41163.37154.6102.8697.49
Operating Expenses
309.24224.09162.71154.77102.8699.61
Operating Income
108.62102.35-0.41-1.0748.353.12
Interest Expense
-14.46-16.57-13-9.19-10.4-11.44
Earnings From Equity Investments
-3.07-3.10.58---
Other Non Operating Income (Expenses)
-2.5----0.47-
EBT Excluding Unusual Items
88.5882.69-12.83-10.2637.4341.68
Gain (Loss) on Sale of Investments
-115.99-115.9939.918.89--
Asset Writedown
--9.4---2
Other Unusual Items
---31.04-14.42--
Pretax Income
-27.41-33.35.44-15.7937.4339.68
Income Tax Expense
4.73-0.139.11.77.748.59
Earnings From Continuing Operations
-32.14-33.17-3.66-17.4829.6931.08
Minority Interest in Earnings
42.1837.71.940--
Net Income
10.044.52-1.72-17.4829.6931.08
Net Income to Common
10.044.52-1.72-17.4829.6931.08
Net Income Growth
-80.19%----4.48%31.91%
Shares Outstanding (Basic)
475475469455360335
Shares Outstanding (Diluted)
475475469480360335
Shares Change (YoY)
0.00%1.16%-2.35%33.27%7.51%16.05%
EPS (Basic)
0.020.01-0.00-0.040.080.09
EPS (Diluted)
0.020.01-0.00-0.040.080.09
EPS Growth
-80.69%----13.70%13.66%
Free Cash Flow
72.9475.69-132.55-285.8915.1738.84
Free Cash Flow Per Share
0.150.16-0.28-0.590.040.12
Dividend Per Share
0.021---0.013-
Gross Margin
41.49%38.59%27.31%32.92%35.22%33.01%
Operating Margin
10.79%12.10%-0.07%-0.23%11.25%11.48%
Profit Margin
1.00%0.53%-0.29%-3.74%6.92%6.72%
Free Cash Flow Margin
7.24%8.95%-22.30%-61.25%3.54%8.39%
EBITDA
160.74147.3834.116.2562.8967.91
EBITDA Margin
15.96%17.42%5.74%3.48%14.66%14.67%
D&A For EBITDA
52.1245.0334.5117.3314.5914.79
EBIT
108.62102.35-0.41-1.0748.353.12
EBIT Margin
10.79%12.10%-0.07%-0.23%11.25%11.48%
Effective Tax Rate
--167.14%-20.68%21.66%
Revenue as Reported
1,007845.93594.36466.8429.13462.74
Advertising Expenses
-43.027.2622.6217.5215.95
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.